The RISE study protocol: Resilience lmpacted by positive Stressful Events for people with cystic fibrosis
Sign Up to like & getrecommendations! Published in 2023 at "ERJ Open Research"
DOI: 10.1183/23120541.00535-2022
Abstract: For people with cystic fibrosis (pwCF), gaining access to elexacaftor/tezacaftor/ivacaftor (ETI) therapy, a new modulator drug combination, is perceived as a positive life event. ETI leads to a strong improvement of disease symptoms. However, some… read more here.
Keywords: eti therapy; people cystic; rise study; therapy ... See more keywords